Home / Import refusals / 1FX-4495920-2/20002/1

FDA Import Refusal 1FX-4495920-2/20002/1 — Intas Pharmaceuticals Limited

Intas Pharmaceuticals Limited — FEI 3000978756

The FDA refused shipment 1FX-4495920-2/20002/1 from Intas Pharmaceuticals Limited (India) on May 13, 2026. The refused product falls under Drugs and Biologics — ATENOLOL (ANTI-ADRENERGIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 13, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
60XCA17 ATENOLOL (ANTI-ADRENERGIC)
Charges
118,75

Other import refusals

  • 1FX-5380728-4/10002/2 (Fri May 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-2344992-8/20002/2 (Fri May 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-2344992-8/20002/1 (Fri May 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4495920-2/20002/4 (Wed May 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0162570-5/40002/1 (Fri Apr 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources